🔴Relating to the establishment of the sickle cell disease registry.
HB 107
🔴 HB 107: State registry for sickle cell data, but with no public access
What it says it does:
HB 107 creates a statewide registry to track sickle cell disease cases in Texas. The goal is to improve research and public health efforts by centralizing data collection.
What it actually changes:
It gives full control of the registry to the Department of State Health Services. The bill blocks the data from being accessed through public records requests and prohibits it from being used in court, even in medical harm cases, unless the patient gave advance consent. The registry is permanent, but implementation is optional if the Legislature does not fund it.
Who is pushing for it:
Supporters listed include Texas Children’s Hospital, Texas Association of Health Plans, Texas Medical Association, Texas Healthcare and Bioscience Institute, Texas Pediatric Society, and the Texas Women’s Healthcare Coalition.
Who benefits:
Large hospital systems and research institutions gain access to centralized data that can help secure funding and drive research. Health plans and medical associations gain legal protections that reduce their exposure to liability. State agencies gain discretion over how the system is built, funded, and managed, without requiring public oversight.
Who gets left out or exposed:
Patients, especially Black Texans who are disproportionately affected by sickle cell disease, have no guaranteed voice in how their data is used. Families may be blocked from using the registry data in court. Rural clinics and underfunded hospitals may still be required to submit data even if the system is not fully funded or active.
Why this matters long term:
HB 107 sets up a permanent legal framework for health surveillance that limits transparency, restricts legal access, and places critical decisions inside state agencies with little public input. It creates a model that could be reused for other registries covering mental health, reproductive care, or disability without community control or accountability.
What to watch next:
Watch who receives the contracts for managing or analyzing registry data. Look for future registry bills that use the same structure. Monitor whether public funding is ever appropriated and how implementation is handled behind the scenes.
Bottom line:
HB 107 says it helps sickle cell patients, but what it builds is a hidden, agency-run system that protects institutions more than people. It restricts access to justice, removes public oversight, and creates a playbook for expanding health data collection without patient rights.
#HB107 #TexasPolicy #TexasHealth #DataPrivacy #StructuralPowerShift #StayInformed